HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saleem, R. A. Articles by Walter, M. A. Search for Related Content PubMed PubMed Citation Articles by Saleem, R. A. Articles by Walter, M. A.

Identification and Analysis of a Novel Mutation in the FOXC1 Forkhead Domain

¹From the Departments of Medical Genetics and ²Ophthalmology, University of Alberta, Edmonton, Alberta, Canada; and ³The New York Eye and Ear Infirmary, New York, New York.

PURPOSE. To determine the genetic and biochemical defects that underlie Axenfeld-Rieger malformations, identify the pathogenic mutation causing these malformations, and understand how these mutations alter protein function.

METHODS. FOXC1 was amplified from a proband with Axenfeld-Rieger malformations and the proband’s mother. PCR products were sequenced to identify the pathogenic mutation. Site-directed mutagenesis was used to introduce this mutation into the FOXC1 cDNA. A synthetic mutation at the same position was also introduced, and both natural and synthetic proteins were tested for their ability to localize to the nucleus, bind DNA, and transactivate gene expression.

RESULTS. A novel missense mutation (L86F) was identified in FOXC1 in this family. The mutation is located in -helix 1 of the forkhead domain. Biochemical assays showed that the L86F mutation does not affect nuclear localization of FOXC1, but reduces DNA binding and significantly reduces transactivation. The severity of the disruption to FOXC1 protein activity does not appear to correspond well with the severity of the phenotype in the patient. Analogous studies using a L86P, a known -helix breaker, severely disrupts FOXC1 function, revealing the importance of helix 1 in FOXC1 structure and function.

CONCLUSIONS. A novel mutation in helix 1 of the FOXC1 forkhead domain has been identified and the importance of position 86 in FOXC1 activity demonstrated. These studies also identified the role of helix 1 in FOXC1 function and provide further evidence for the lack of strong genotype–phenotype correlation in FOXC1 pathogenesis. Normal development appears to be dependent on tight upper and lower thresholds of FOXC1 activity.

This article has been cited by other articles:

				S. Chakrabarti, K. Kaur, K. N. Rao, A. K. Mandal, I. Kaur, R. S. Parikh, and R. Thomas The Transcription Factor Gene FOXC1 Exhibits a Limited Role in Primary Congenital Glaucoma Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 75 - 83. [Abstract] [Full Text] [PDF]

				L. Huang, J. Chi, F. B. Berry, T. K. Footz, M. W. Sharp, and M. A. Walter Human p32 Is a Novel FOXC1-Interacting Protein That Regulates FOXC1 Transcriptional Activity in Ocular Cells Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5243 - 5249. [Abstract] [Full Text] [PDF]

				M. H. Strungaru, I. Dinu, and M. A. Walter Genotype-Phenotype Correlations in Axenfeld-Rieger Malformation and Glaucoma Patients with FOXC1 and PITX2 Mutations Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 228 - 237. [Abstract] [Full Text] [PDF]

				Y. Tamimi, J. M. Skarie, T. Footz, F. B. Berry, B. A. Link, and M. A. Walter FGF19 is a target for FOXC1 regulation in ciliary body-derived cells Hum. Mol. Genet., November 1, 2006; 15(21): 3229 - 3240. [Abstract] [Full Text] [PDF]

				N. Weisschuh, P. Dressler, F. Schuettauf, C. Wolf, B. Wissinger, and E. Gramer Novel Mutations of FOXC1 and PITX2 in Patients with Axenfeld-Rieger Malformations. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3846 - 3852. [Abstract] [Full Text] [PDF]

				W. Cella, J. P. Cabral de Vasconcellos, M. Barbosa de Melo, B. Kneipp, F. F. Costa, C. A. Longui, and V. P. Costa Structural Assessment of PITX2, FOXC1, CYP1B1, and GJA1 Genes in Patients with Axenfeld-Rieger Syndrome with Developmental Glaucoma Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1803 - 1809. [Abstract] [Full Text] [PDF]

				F. B. Berry, Y. Tamimi, M. V. Carle, O. J. Lehmann, and M. A. Walter The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis Hum. Mol. Genet., September 15, 2005; 14(18): 2619 - 2627. [Abstract] [Full Text] [PDF]

				F. B. Berry, M. A. O'Neill, M. Coca-Prados, and M. A. Walter FOXC1 Transcriptional Regulatory Activity Is Impaired by PBX1 in a Filamin A-Mediated Manner Mol. Cell. Biol., February 15, 2005; 25(4): 1415 - 1424. [Abstract] [Full Text] [PDF]

				R. A. Saleem, S. Banerjee-Basu, T. C. Murphy, A. Baxevanis, and M. A. Walter Essential structural and functional determinants within the forkhead domain of FOXC1 Nucleic Acids Res., August 6, 2004; 32(14): 4182 - 4193. [Abstract] [Full Text] [PDF]

				T. C. Murphy, R. A. Saleem, T. Footz, R. Ritch, B. McGillivray, and M. A. Walter The Wing 2 Region of the FOXC1 Forkhead Domain Is Necessary for Normal DNA-Binding and Transactivation Functions Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2531 - 2538. [Abstract] [Full Text] [PDF]